Written exposure therapy delivered to Veterans by tele-therapists for post-traumatic stress disorder

Implementation of written exposure therapy for PTSD in Veterans Affairs telehealth clinical resource hubs

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN57637812

Enrollment

640

Registered

2022-10-12

Start date

2022-10-15

Completion date

Unknown

Last updated

2025-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Posttraumatic Stress Disorder Mental and Behavioural Disorders

Interventions

The interventions are not clinical interventions, they are implementation strategies designed to promote the adoption of evidence-based practice into routine care. Implementation Strategy 1 - Therapi

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Enrollee in the United States Department of Veterans Affairs 2. Primary diagnosis of post-traumatic stress disorder at an intake encounter

Exclusion criteria

Exclusion criteria: Does not meet the inclusion criteria

Design outcomes

Primary

Measure	Time frame
Current primary outcome measure as of 20/10/2025: Reach at the patient level, defined as whether the patient received the WET intervention, measured using chart reviews during the time period between the intake visit and 6 months later Previous primary outcome measure: Reach at the patient level, defined as whether the patient received the WET intervention, measured using chart reviews during the time period between the intake visit and 4 months later	—

Measure

Time frame

Current primary outcome measure as of 20/10/2025: Reach at the patient level, defined as whether the patient received the WET intervention, measured using chart reviews during the time period between the intake visit and 6 months later Previous primary outcome measure: Reach at the patient level, defined as whether the patient received the WET intervention, measured using chart reviews during the time period between the intake visit and 4 months later

—

Secondary

Measure	Time frame
Current secondary outcome measures as of 20/10/2025: 1. Clinical effectiveness at the patient level measured using the PTSD Check List for DSM-V (PCL-5) survey to assess PTSD symptom severity and the Brief Inventory of Psychosocial Functioning (B-IPF) to assess relationship functioning at baseline and 6 months 2. Adoption at the therapist level measured using chart reviews to measure what proportion of each therapist’s patients with PTSD received WET versus some other type of counseling during the six months after their intake visit 3. Mechanisms of action measured using provider surveys at 1, 2, 3, 4, 5, and 6 months after external facilitation began, including: 3.1. Self-efficacy for PTSD treatment planning 3.2. Attitude about WET 3.3. Self-efficacy for delivering WET 3.4. Usability for sharing trauma narratives 3.5. Clinical Resource Hub (CRH) therapist support for delivering WET Previous secondary outcome measures: 1. Clinical effectiveness at the patient level measured using the PTSD Check List for DSM-V (PCL-5) survey to assess PTSD symptom severity and the Brief Inventory of Psychosocial Functioning (B-IPF) to assess relationship functioning at baseline and 4 months 2. Adoption at the therapist level measured using chart reviews to measure what proportion of each therapist’s patients with PTSD received WET versus some other type of counseling during the six months of external facilitation 3. Mechanisms of action measured using provider surveys at 1, 2, 3, 4, 5, and 6 months after external facilitation began, including: 3.1. Self-efficacy for PTSD treatment planning 3.2. Attitude about WET 3.3. Self-efficacy for delivering WET 3.4. Usability for sharing trauma narratives 3.5. Clinical Resource Hub (CRH) therapist support for delivering WET	—

Measure

Time frame

Current secondary outcome measures as of 20/10/2025: 1. Clinical effectiveness at the patient level measured using the PTSD Check List for DSM-V (PCL-5) survey to assess PTSD symptom severity and the Brief Inventory of Psychosocial Functioning (B-IPF) to assess relationship functioning at baseline and 6 months 2. Adoption at the therapist level measured using chart reviews to measure what proportion of each therapist’s patients with PTSD received WET versus some other type of counseling during the six months after their intake visit 3. Mechanisms of action measured using provider surveys at 1, 2, 3, 4, 5, and 6 months after external facilitation began, including: 3.1. Self-efficacy for PTSD treatment planning 3.2. Attitude about WET 3.3. Self-efficacy for delivering WET 3.4. Usability for sharing trauma narratives 3.5. Clinical Resource Hub (CRH) therapist support for delivering WET Previous secondary outcome measures: 1. Clinical effectiveness at the patient level measured using the PTSD Check List for DSM-V (PCL-5) survey to assess PTSD symptom severity and the Brief Inventory of Psychosocial Functioning (B-IPF) to assess relationship functioning at baseline and 4 months 2. Adoption at the therapist level measured using chart reviews to measure what proportion of each therapist’s patients with PTSD received WET versus some other type of counseling during the six months of external facilitation 3. Mechanisms of action measured using provider surveys at 1, 2, 3, 4, 5, and 6 months after external facilitation began, including: 3.1. Self-efficacy for PTSD treatment planning 3.2. Attitude about WET 3.3. Self-efficacy for delivering WET 3.4. Usability for sharing trauma narratives 3.5. Clinical Resource Hub (CRH) therapist support for delivering WET

—

Countries

United States of America

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026